[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2016-2020 Survey of the Automated Microbiology Market in 33 Countries: Supplier Shares, Sales and Volume Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

May 2016 | 1000 pages | ID: 28B4F9D6998EN
Venture Planning Group

US$ 43,600.00 US$ 54,500.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive 33-country survey will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Geographic Coverage

Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, USA

Specimen Types
  • Urine
  • Sterile Fluids: Blood, Serum, CSF
  • Throat Swabs, Respiratory Secretions
  • Genital Secretions
  • Stool
  • Abscess/Wound
  • Sputum
  • Saliva
Applications
  • Microbial Identification
  • Antibiotic Susceptibility
  • Urine Screening
  • Blood Cultures
Review of Major Automated Systems
  • Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.
Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus, Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia

Technology Review
  • Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
  • Companies developing or marketing microbiology products, by individual test.
Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R D.

Opportunities and Strategic Recommendations
  • Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
  • Design criteria for decentralized testing products.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
Contains over 1,000 pages and 550 tables
1. INTRODUCTION

2. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

3. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

4. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

5. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

6. WORLDWIDE MARKET AND TECHNOLOGY REVIEW

A. DNA Sequencing
  1. INTRODUCTION
  2. SEQUENCING METHODS
  3. AUTORADIOGRAPHY
  4. THE HUMAN GENOME PROJECT
  5. SEQUENCING AUTOMATION
  6. IMAGE SCANNERS
  7. FLUORESCENT DETECTION
  8. GENE PROFILING
  9. GENE EXPRESSION
  10. POLYMORPHISM SCREENING
  11. PROTEIN INTERACTION NETWORKS
B. DNA and RNA Probe Technologies
  1. BASIC PRINCIPLES
  2. PROBE PREPARATION
  3. THE DNA PROBE TEST
  4. TEST FORMATS
  5. LABELING TECHNIQUES
  6. AMPLIFICATION METHODS
C. Detection Technologies
  1. RADIOACTIVE METHODS
    a. Overview
    b. Major Isotopes
  2. NONISOTOPIC METHODS
    a. Enzymatic Labels
    b. Chemical Labeling
    c. Fluorescence
    d. Chemiluminescence
    e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
  1. ABBOTT LCX
  2. BECKMAN COULTER/BIOMEK FK
  3. BD VIPER SYSTEM WITH XTR TECHNOLOGY
  4. BD INNOVA
  5. BECTON DICKINSON SDA
  6. BIOMERIEUX NUCLISENS EASYMAG
  7. BIOMERIEUX NUCLISENS EASYQ AND MINIMAG
  8. BIO RAD GENESCOPE
  9. CEPHEID GENEXPERT
  10. CURETIS UNYVERO
  11. GENMARK DX ESENSOR XT    8
  12. HOLOGIC/GENROBE PANTHER
  13. HOLOGIC/GENROBE TIGRIS/DTS
  14. HTG MOLECULAR EDGE
  15. LIFE TECHNOLOGIES QUANTSTUDI  DX
  16. QIAGEN QIASYMPHONY RGQ
  17. ROCHE COBAS AMPLICOR
  18. ROCHE COBAS TAQMAN
  19. ROCHE COBAS TAQMAN
  20. ROCHE COBAS TAQMAN AMPLIPREP
  21. ROCHE LIGHCYCLER
  22. ROCHE COBAS 4800
  23. ROCHE COBAS S
  24. SIEMENS VERSANT
  25. TECAN LS SERIES
E. Biochips: Genosensors, Microarrays, Labs on    the Chip
  Liquid Transportation and Mixing
  Separation
  Reaction
  Detection
F. Pharmacogenomics
G. Major Applications
  1. MICROBIOLOGY/INFECTIOUS DISEASES
    a. Overview
    b. Major Infectious Diseases
  AIDS/HIV

  Adenovirus
  Aeromonads
  Anthrax/Bacillus Anthracis
  Arboviruses
  Babesiosis
  Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
  Blastocystis Hominis
  Brucella
  Campylobacter
  Candida
  Chagas Disease
  Chancroid
  Chlamydia
  Clostridium Difficile
  Coronaviruses
  Coxsackieviruses
  Creutzfeldt Jakob’s Disease
  Cryptosporidium Parvum
  Cyclospora Cayetanensis
  Cytomegalovirus
  Ebola Virus
  E. Coli
  EchoVirus
  Encephalitis
  Enteroviruses
  Epstein    Barr Virus
  Giardia Lamblia
  Gonorrhea
  Granuloma Inguinale
  Hantavirus
  Helicobacter Pylori
  Hepatitis
  Herpes Simplex Virus
  Human Herpes Virus 6 (HHV    6)
  Influenza Viruses
  Legionella
  Lyme Disease
  Lymphogranuloma Venereum (LGV)
  Malaria
  Measles (Rubeola)
  Meningitis
  Microsporidium
  Mononucleosis
  Mumps
  Mycoplasma
  Papillomaviruses
  Parvovirus B19
  Pneumonia
  Polyomaviruses
  Pseudomonas Aeruginosa
  Rabies
  Respiratory Syncytial Virus (RSV)
  Rhinoviruses
  Rotavirus
  Rubella
  Salmonellosis
  Septicemia
  Shigellosis
  Staphylococcus Aureus
  Streptococci
  Syphilis
  Toxoplasmosis
  Trichomonas Vaginalis
  Tuberculosis
  Vibrio
  West Nile Virus
  Yersina
  2. CANCER TESTING
    a. Overview
    b. Major Cancer Types
  Prostate
  Lung
  Colon and Rectum
  Breast
  Skin
  Uterine
  Leukemia
  Oral
    c. Oncogenes
  Abl/abl bcr
  AIB1
  BCL2
  BRCA1
  CD44
  C-fos
  C-myb
  C-myc
  CYP17
  ErbB
  HPC1
  Nmyc
  P40
  P51
  P53
  PIK3CA
  PTI1
  Ras
  Reg
  Sis
  Src
  3. GENETIC DISEASES
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
    f. Current Pharmacogenomic Tests
    g. Future Pharmacogenomic Testing
    h. Major Diseases
  Achondroplasia
  Autosomal Dominant Polycystic Kidney Disease
  Cancer
  Cosmetogenomics
  Cystic Fibrosis
  Down's Syndrome
  Duchenne and Becker Muscular Dystrophy
  Factor V (Leiden)
  Factor IX Deficiency
  Fragile X Syndrome
  Heart Disease
  Hemochomatosis
  Hemophilia
  Huntington's Disease
  Maternal Fetal Incompatibility
  Multiple Endocrine Neoplasia
  Phenylketonuria (PKU)
  Polycystic Kidney Disease (PKD)
  Prenatal Screening
  Retinitis Pigmentosa
  Retinoblastoma
  Sickle Cell Anemia
  Spinal Muscular Atrophy
  Vitamin B12 Metabolism
    i. Social Issues and Concerns
  4. FORENSIC TESTING
    a. Overview
    b. Multilocus and Single Locus Probes
    c. DNA Profile Data Banks
    d. Judicial Implementation
    e. Major Crime Categories
    f. Factors Contributing to the DNA Probe Market Expansion
  Technology Availability
  Use of Hair as Evidence
    g. Wildlife Forensics
  5. PATERNITY TESTING/HLA TYPING
  6. OTHER APPLICATIONS
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    d. Alzheimer's Disease
    e. Periodontal Disease
    f. Plasma Purification
    g. Organ Transplantation
    h. Water Contamination
    i. Other
H. Competing/complementing
  1. MONOCLONAL ANTIBODIES/IMMUNOASSAYS
  2. RNA PROBES
  3. TWO DIMENSIONAL ELECTROPHORESIS
  4. FLOW CYTOMETRY

7. COUNTRY ANALYSES: VOLUME AND SALES FORECASTS        INFECTIOUS DISEASES, GENETIC DISEASES, CANCER, FORENSIC AND PATERNITY TESTING

  Australia
  Austria
  Belgium
  Bulgaria
  Canada
  Cyprus
  Czech Republic
  Denmark
  Estonia
  Finland
  France
  Germany
  Greece
  Hungary
  Iceland
  Ireland
  Italy
  Japan
  Latvia
  Lithuania
  Malta
  Netherlands
  Norway
  Poland
  Portugal
  Romania
  Slovakia Table of Contents (continued)
  Slovenia
  Spain
  Sweden
  Switzerland
  UK
  USA

8. COMPETITIVE ASSESSMENTS

  Abbott
  Affymetrix/Thermo Fisher
  Agilent Technologies
  Applied Gene Technologies
  Arca Biopharma
  Beckman Coulter/Danaher
  Becton Dickinson
  Biokit
  bioMerieux
  Bio-Rad
  Biotest
  CellMark Forensics/LabCorp
  Cepheid
  Decode Genetics
  Diadexus
  Eiken
  Elitech Group
  Enzo
  Exact Sciences
  Fujirebio
  Grifols
  Hologic/Genrobe
  Illumina
  Kreatech/Leica
  Li Cor Biosciences
  Monogram Biosciences/LabCorp
  Myriad Genetics
  Ortho    Clinical Diagnostics
  Perkin Elmer/Caliper
  Proteome Sciences
  Qiagen
  Roche
  Scienion
  Sequenom
  Shimadzu
  Siemens
  Sierra Molecular
  Takara Bio
  Tecan Group

9. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING INNOVATIVE MOLECULAR DIAGNOSTIC TECHNOLOGIES AND PRODUCTS

LIST OF TABLES

Australia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Australia Molecular Diagnostics Test Volume Forecasts by Application
Australia Major Infectious Disease Test Volume Forecasts by Assay
Australia Molecular Diagnostics Market Forecasts by Application
Australia Major Infectious Disease Diagnostics Market Forecasts by Assay
Austria Molecular Diagnostics Test Volume and Sales Forecasts by Application
Austria Molecular Diagnostics Test Volume Forecasts by Application
Austria Major Infectious Disease Test Volume Forecasts by Assay
Austria Molecular Diagnostics Market Forecasts by Application
Austria Major Infectious Disease Diagnostics Market Forecasts by Assay
Belgium Molecular Diagnostics Test Volume and Sales Forecasts by Application
Belgium Molecular Diagnostics Test Volume Forecasts by Application
Belgium Major Infectious Disease Test Volume Forecasts by Assay
Belgium Molecular Diagnostics Market Forecasts by Application
Belgium Major Infectious Disease Diagnostics Market Forecasts by Assay
Bulgaria Molecular Diagnostics Test Volume and Sales Forecasts by Application
Bulgaria Molecular Diagnostics Test Volume Forecasts by Application
Bulgaria Major Infectious Disease Test Volume Forecasts by Assay
Bulgaria Molecular Diagnostics Market Forecasts by Application
Bulgaria Major Infectious Disease Diagnostics Market Forecasts by Assay
Canada Molecular Diagnostics Test Volume and Sales Forecasts by Application
Canada Molecular Diagnostics Test Volume Forecasts by Application
Canada Major Infectious Disease Test Volume Forecasts by Assay
Canada Molecular Diagnostics Market Forecasts by Application
Canada Major Infectious Disease Diagnostics Market Forecasts by Assay
Cyprus Molecular Diagnostics Test Volume and Sales Forecasts by Application
Cyprus Molecular Diagnostics Test Volume Forecasts by Application
Cyprus Major Infectious Disease Test Volume Forecasts by Assay
Cyprus Molecular Diagnostics Market Forecasts by Application
Cyprus Major Infectious Disease Diagnostics Market Forecasts by Assay
Czech Republic Molecular Diagnostics Test Volume and Sales Forecasts by Application
Czech Republic Molecular Diagnostics Test Volume Forecasts by Application
Czech Republic Major Infectious Disease Test Volume Forecasts by Assay
Czech Republic Molecular Diagnostics Market Forecasts by Application
Czech Republic Major Infectious Disease Diagnostics Market Forecasts by Assay
Denmark Molecular Diagnostics Test Volume and Sales Forecasts by Application
Denmark Molecular Diagnostics Test Volume Forecasts by Application
Denmark Major Infectious Disease Test Volume Forecasts by Assay
Denmark Molecular Diagnostics Market Forecasts by Application
Denmark Major Infectious Disease Diagnostics Market Forecasts by Assay
Estonia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Estonia Molecular Diagnostics Test Volume Forecasts by Application
Estonia Major Infectious Disease Test Volume Forecasts by Assay
Estonia Molecular Diagnostics Market Forecasts by Application
Estonia Major Infectious Disease Diagnostics Market Forecasts by Assay
Finland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Finland Molecular Diagnostics Test Volume Forecasts by Application
Finland Major Infectious Disease Test Volume Forecasts by Assay
Finland Molecular Diagnostics Market Forecasts by Application
Finland Major Infectious Disease Diagnostics Market Forecasts by Assay
France Molecular Diagnostics Test Volume and Sales by Major Application
France Laboratories Performing DNA Sequencing by Market Segment
France Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France Molecular Diagnostics Test Volume by Major Application
France Major Infectious Disease Test Volume by Assay
France Major Infectious Disease Test Volume by Method
France Molecular Diagnostics Market by Major Application
France Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
France Major Infectious Disease Diagnostics Market by Assay
France AIDS Testing Market Estimated Sales by Major Supplier
France Adenovirus Testing Market Estimated Sales by Major Supplier
France Chlamydia Testing Market Estimated Sales by Major Supplier
France CMV Testing Market Estimated Sales by Major Supplier
France Gonorrhea Testing Market Estimated Sales by Major Supplier
France Hepatitis Testing Market Estimated Sales by Major Supplier
France Hepatitis C Testing Market Estimated Sales by Major Supplier
France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
France Herpes Testing Market Estimated Sales by Major Supplier
France Influenza Testing Market Estimated Sales by Major Supplier
France Meningitis Testing Market Estimated Sales by Major Supplier
France Mycoplasma Testing Market Estimated Sales by Major Supplier
France RSV Testing Market Estimated Sales by Major Supplier
France Shigella Testing Market Estimated Sales by Major Supplier
Germany Molecular Diagnostics Test Volume and Sales by Major Application
Germany Laboratories Performing DNA Sequencing by Market Segment
Germany Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany Molecular Diagnostics Test Volume by Major Application
Germany Major Infectious Disease Test Volume by Assay
Germany Major Infectious Disease Test Volume by Method
Germany Molecular Diagnostics Market by Major Application
Germany Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Germany Major Infectious Disease Diagnostics Market by Assay
Germany AIDS Testing Market Estimated Sales by Major Supplier
Germany CMV Testing Market Estimated Sales by Major Supplier
Germany EBV Testing Market Estimated Sales by Major Supplier
Germany Gonorrhea Testing Market Estimated Sales by Major Supplier
Germany Hepatitis Testing Market Estimated Sales by Major Supplier
Germany Hepatitis C Testing Market Estimated Sales by Major Supplier
Germany HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Germany Herpes Testing Market Estimated Sales by Major Supplier
Germany Influenza Testing Market Estimated Sales by Major Supplier
Germany Meningitis Testing Market Estimated Sales by Major Supplier
Germany Mycoplasma Testing Market Estimated Sales by Major Supplier
Germany Pneumonia Testing Market Estimated Sales by Major Supplier
Germany RSV Testing Market Estimated Sales by Major Supplier
Germany Rotavirus Testing Market Estimated Sales by Major Supplier
Greece Molecular Diagnostics Test Volume and Sales Forecasts by Application
Greece Molecular Diagnostics Test Volume Forecasts by Application
Greece Major Infectious Disease Test Volume Forecasts by Assay
Greece Molecular Diagnostics Market Forecasts by Application
Greece Major Infectious Disease Diagnostics Market Forecasts by Assay
Hungary Molecular Diagnostics Test Volume and Sales Forecasts by Application
Hungary Molecular Diagnostics Test Volume and Sales Forecasts by Application
Hungary Molecular Diagnostics Test Volume Forecasts by Application
Hungary Major Infectious Disease Test Volume Forecasts by Assay
Hungary Molecular Diagnostics Market Forecasts by Application
Hungary Major Infectious Disease Diagnostics Market Forecasts by Assay
Iceland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Iceland Molecular Diagnostics Test Volume Forecasts by Application
Iceland Major Infectious Disease Test Volume Forecasts by Assay
Iceland Molecular Diagnostics Market Forecasts by Application
Iceland Major Infectious Disease Diagnostics Market Forecasts by Assay
Ireland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Ireland Molecular Diagnostics Test Volume Forecasts by Application
Ireland Major Infectious Disease Test Volume Forecasts by Assay
Ireland Molecular Diagnostics Market Forecasts by Application
Ireland Major Infectious Disease Diagnostics Market Forecasts by Assay
Italy Molecular Diagnostics Test Volume and Sales by Major Application
Italy Laboratories Performing DNA Sequencing by Market Segment
Italy Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Italy Molecular Diagnostics Test Volume by Major Application
Italy Major Infectious Disease Test Volume by Assay
Italy Major Infectious Disease Test Volume by Method
Italy Molecular Diagnostics Market by Major Application
Italy Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Italy Major Infectious Disease Diagnostics Market by Assay
Italy AIDS Testing Market Estimated Sales by Major Supplier
Italy CMV Testing Market Estimated Sales by Major Supplier
Italy Gonorrhea Testing Market Estimated Sales by Major Supplier
Italy Hepatitis Testing Market Estimated Sales by Major Supplier
Italy Hepatitis C Testing Market Estimated Sales by Major Supplier
Italy HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Italy Herpes Testing Market Estimated Sales by Major Supplier
Italy Influenza Testing Market Estimated Sales by Major Supplier
Italy Meningitis Testing Market Estimated Sales by Major Supplier
Italy Mycoplasma Testing Market Estimated Sales by Major Supplier
Italy RSV Testing Market Estimated Sales by Major Supplier
Japan Molecular Diagnostics Test Volume and Sales by Major Application
Japan Laboratories Performing DNA Sequencing by Market Segment
Japan Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan Molecular Diagnostics Test Volume by Major Application
Japan Major Infectious Disease Test Volume by Assay
Japan Major Infectious Disease Test Volume by Method
Japan Molecular Diagnostics Market by Major Application
Japan Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Japan Major Infectious Disease Diagnostics Market by Assay
Japan AIDS Testing Market Estimated Sales by Major Supplier
Japan Chlamydia Testing Market Estimated Sales by Major Supplier
Japan CMV Testing Market Estimated Sales by Major Supplier
Japan Gonorrhea Testing Market Estimated Sales by Major Supplier
Japan Hepatitis Testing Market Estimated Sales by Major Supplier
Japan Hepatitis C Testing Market Estimated Sales by Major Supplier
Japan Herpes Testing Market Estimated Sales by Major Supplier
Japan Meningitis Testing Market Estimated Sales by Major Supplier
Japan Mycoplasma Testing Market Estimated Sales by Major Supplier
Japan Pneumonia Testing Market Estimated Sales by Major Supplier
Japan Shigella Testing Market Estimated Sales by Major Supplier
Latvia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Latvia Molecular Diagnostics Test Volume Forecasts by Application
Latvia Major Infectious Disease Test Volume Forecasts by Assay
Latvia Molecular Diagnostics Market Forecasts by Application
Latvia Major Infectious Disease Diagnostics Market Forecasts by Assay
Lithuania Molecular Diagnostics Test Volume and Sales Forecasts by Application
Lithuania Molecular Diagnostics Test Volume Forecasts by Application
Lithuania Major Infectious Disease Test Volume Forecasts by Assay
Lithuania Molecular Diagnostics Market Forecasts by Application
Lithuania Major Infectious Disease Diagnostics Market Forecasts by Assay
Malta Molecular Diagnostics Test Volume and Sales Forecasts by Application
Malta Molecular Diagnostics Test Volume Forecasts by Application
Malta Major Infectious Disease Test Volume Forecasts by Assay
Malta Molecular Diagnostics Market Forecasts by Application
Malta Major Infectious Disease Diagnostics Market Forecasts by Assay
Netherlands Molecular Diagnostics Test Volume and Sales Forecasts by Application
Netherlands Molecular Diagnostics Test Volume Forecasts by Application
Netherlands Major Infectious Disease Test Volume Forecasts by Assay
Netherlands Molecular Diagnostics Market Forecasts by Application
Netherlands Major Infectious Disease Diagnostics Market Forecasts by Assay
Norway Molecular Diagnostics Test Volume and Sales Forecasts by Application
Norway Molecular Diagnostics Test Volume Forecasts by Application
Norway Major Infectious Disease Test Volume Forecasts by Assay
Norway Molecular Diagnostics Market Forecasts by Application
Norway Major Infectious Disease Diagnostics Market Forecasts by Assay
Poland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Poland Molecular Diagnostics Test Volume Forecasts by Application
Poland Major Infectious Disease Test Volume Forecasts by Assay
Poland Molecular Diagnostics Market Forecasts by Application
Poland Major Infectious Disease Diagnostics Market Forecasts by Assay
Portugal Molecular Diagnostics Test Volume and Sales Forecasts by Application
Portugal Molecular Diagnostics Test Volume Forecasts by Application
Portugal Major Infectious Disease Test Volume Forecasts by Assay
Portugal Major Infectious Disease Diagnostics Market Forecasts by Assay
Romania Molecular Diagnostics Test Volume and Sales Forecasts by Application
Romania Molecular Diagnostics Test Volume Forecasts by Application
Romania Major Infectious Disease Test Volume Forecasts by Assay
Romania Molecular Diagnostics Market Forecasts by Application
Romania Major Infectious Disease Diagnostics Market Forecasts by Assay
Slovakia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Slovakia Molecular Diagnostics Test Volume Forecasts by Application
Slovakia Major Infectious Disease Test Volume Forecasts by Assay
Slovakia Molecular Diagnostics Market Forecasts by Application
Slovakia Major Infectious Disease Diagnostics Market Forecasts by Assay
Slovenia Molecular Diagnostics Test Volume and Sales Forecasts by Application
Slovenia Molecular Diagnostics Test Volume Forecasts by Application
Slovenia Major Infectious Disease Test Volume Forecasts by Assay
Slovenia Molecular Diagnostics Market Forecasts by Application
Slovenia Major Infectious Disease Diagnostics Market Forecasts by Assay
Spain Molecular Diagnostics Test Volume and Sales by Major Application
Spain Laboratories Performing DNA Sequencing by Market Segment
Spain Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Spain Molecular Diagnostics Test Volume by Major Application
Spain Major Infectious Disease Test Volume by Assay
Spain Major Infectious Disease Test Volume by Method
Spain Molecular Diagnostics Market by Major Application
Spain Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Spain Major Infectious Disease Diagnostics Market by Assay
Spain AIDS Testing Market Estimated Sales by Major Supplier
Spain Chlamydia Testing Market Estimated Sales by Major Supplier
Spain CMV Testing Market Estimated Sales by Major Supplier
Spain Gonorrhea Testing Market Estimated Sales by Major Supplier
Spain Hepatitis Testing Market Estimated Sales by Major Supplier
Spain Hepatitis C Testing Market Estimated Sales by Major Supplier
Spain HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Spain Herpes Testing Market Estimated Sales by Major Supplier
Spain Influenza Testing Market Estimated Sales by Major Supplier
Spain Meningitis Testing Market Estimated Sales by Major Supplier
Spain Mycoplasma Testing Market Estimated Sales by Major Supplier
Sweden Molecular Diagnostics Test Volume and Sales Forecasts by Application
Sweden Molecular Diagnostics Test Volume Forecasts by Application
Sweden Major Infectious Disease Test Volume Forecasts by Assay
Sweden Molecular Diagnostics Market Forecasts by Application
Sweden Major Infectious Disease Diagnostics Market Forecasts by Assay
Switzerland Molecular Diagnostics Test Volume and Sales Forecasts by Application
Switzerland Molecular Diagnostics Test Volume Forecasts by Application
Switzerland Major Infectious Disease Test Volume Forecasts by Assay
Switzerland Molecular Diagnostics Market Forecasts by Application
Switzerland Major Infectious Disease Diagnostics Market Forecasts by Assay
U.K. Molecular Diagnostics Test Volume and Sales by Major Application
U.K. Laboratories Performing DNA Sequencing by Market Segment
U.K. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K. Molecular Diagnostics Test Volume by Major Application
U.K. Major Infectious Disease Test Volume by Assay
U.K. Major Infectious Disease Test Volume by Method
U.K. Molecular Diagnostics Market by Major Application
U.K. Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
U.K. Major Infectious Disease Diagnostics Market by Assay
U.K. AIDS Testing Market Estimated Sales by Major Supplier
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K. Influenza Testing Market Estimated Sales by Major Supplier
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
U.K. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. Molecular Diagnostics Test Volume and Sales by Major Application
U.S.A. Laboratories Performing DNA Sequencing by Market Segment
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K. Influenza Testing Market Estimated Sales by Major Supplier
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
U.K. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. Molecular Diagnostics Test Volume and Sales by Major Application
U.S.A. Laboratories Performing DNA Sequencing by Market Segment
U.S.A. Echovirus Testing Market Estimated Sales by Major Supplier
U.S.A. Enterovirus Testing Market Estimated Sales by Major Supplier
U.S.A. EBV Testing Market Estimated Sales by Major Supplier
U.S.A. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.S.A. Hepatitis Testing Market Estimated Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.S.A. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.S.A. Herpes Testing Market Estimated Sales by Major Supplier
U.S.A. Influenza Testing Market Estimated Sales by Major Supplier
U.S.A. Meningitis Testing Market Estimated Sales by Major Supplier
U.S.A. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.S.A. Pneumonia Testing Market Estimated Sales by Major Supplier
U.S.A. Rabies Testing Market Estimated Sales by Major Supplier
U.S.A. RSV Testing Market Estimated Sales by Major Supplier
U.S.A. Salmonella Testing Market Estimated Sales by Major Supplier
U.S.A. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. West Nile Virus Nat Market Reagent Sales by Major Supplier
Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests for Genetic Diseases


More Publications